Related Experiment Video
Updated: Oct 3, 2025

09:47
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
1.3K
On Improved 3D-CNN-Based Binary and Multiclass Classification of Alzheimer's Disease Using Neuroimaging Modalities
Ahsan Bin Tufail1,2, Kalim Ullah3, Rehan Ali Khan4
1School of Electronics and Information Engineering, Harbin Institute of Technology, Harbin 150001, China.
Journal of Healthcare Engineering
|February 21, 2022
Summary
Random zoomed augmentation best improves early Alzheimer's diagnosis using deep learning with brain scans (MRI/PET). Combining methods or deeper networks did not enhance performance, highlighting data augmentation's critical role.
Area of Science:
- Medical Imaging
- Artificial Intelligence
- Neurology
Background:
- Alzheimer's disease (AD) is a progressive neurodegenerative disorder affecting elderly populations globally.
- Neuroimaging techniques like MRI and PET are crucial for detecting pathological brain changes in early AD.
- Deep learning (DL) models, particularly Convolutional Neural Networks (CNNs), show promise in analyzing medical images for disease diagnosis.
Purpose of the Study:
- To evaluate the impact of different data augmentation techniques on CNN performance for early Alzheimer's disease diagnosis.
- To compare the effectiveness of various augmentation strategies in 3D neuroimaging (MRI and PET) classification tasks.
- To investigate the influence of data augmentation versus architecture design on diagnostic accuracy.
Main Methods:
- Three distinct data augmentation techniques were applied to 3D MRI and PET neuroimaging datasets.
- Convolutional Neural Network (CNN) architectures were employed for both binary and multiclass classification of Alzheimer's disease.
- Performance metrics were analyzed to compare the efficacy of each augmentation method and architectural variations.
Main Results:
- Random zoomed in/out augmentation demonstrated superior performance compared to other tested methods.
- Combining multiple data augmentation techniques often led to decreased classification performance.
- Data augmentation strategies had a more significant impact on performance than architectural modifications or network depth.
Conclusions:
- Random zoomed augmentation is a highly effective technique for enhancing CNN-based early Alzheimer's diagnosis using neuroimaging data.
- Careful selection and application of data augmentation are critical, as inappropriate combinations can be detrimental.
- Focusing on data manipulation techniques may yield better diagnostic improvements than solely relying on complex network architectures or deeper models.
Related Concept Videos
Alzheimer's Disease: Overview
713
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
713
Alzheimer's Disease: Treatment
279
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
279

